GS
BIIB icon

George Soros’s Biogen BIIB Stock Holding History

George Soros’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,994
Closed -$624K – 217
2016
Q3 		$624K Buy
+1,994
New +$591K 0.02% 153
2014
Q2 		– Sell
-7,500
Closed -$2.29M – 374
2014
Q1 		$2.29M Buy
+7,500
New +$2.38M 0.02% 222

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

George Soros's BIIB Position: Q4 2016 in Review

George Soros sold out of Biogen (BIIB) in Q4 2016, closing a stake of 1,994 shares — an estimated $624K sold.

George Soros first reported a position in BIIB in Q1 2014 and held it in 2 quarters. The position peaked at $2.29M in Q1 2014. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • George Soros reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • George Soros sold 1,994 Biogen shares in Q4 2016, an estimated $624K.
  • George Soros first reported a position in Biogen in Q1 2014 and held it in 2 quarters.
  • George Soros's Biogen position peaked at $2.29M in Q1 2014.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Soros Fund Management's 13F filing for Q4 2016, filed 14 Feb 2017.